Opportunity To Invest in Israeli Medical Technology—Ann Arbor

Opportunity To Invest in Early-Stage
Israeli Medical Technology Companies

Presented by Trendlines and OurCrowd

Join Trendlines, a leader in developing early-stage Israeli companies, and OurCrowd, the Israel-based equity crowd-funding platform,
for early-stage investment opportunities in Israel.

Accredited investors are invited to an afternoon event to hear presentations by innovative medtech start-ups and to learn more about Trendlines and OurCrowd.

Meet the entrepreneurs and learn how their innovations are positioned to improve the human condition.

Presenting early-stage Trendlines companies:

CoreBone:

a natural bone graft material for enhanced strength and healing in orthopedic and dental procedures. CoreBone’s patented technology embeds bioactive minerals into the skeleton of corals during the growth process, producing an advanced coral bone substitute material with a high level of bioactivity and ability to integrate with bone.

Gordian Surgical:

Gordian Surgical makes a unique 2-in-1 device that opens and closes incisions during laparoscopic surgery, saving physician time and preventing complications.

ProArc Medical:

ProArc has created ClearRing, a unique prostatic reshaping device that treats Lower Urinary Tract symptoms due to prostate enlargement. ClearRing is a minimally invasive solution that offers immediate symptom relief after a procedure that can be performed in a physician's office.

SensoGo:

SenseGo is a portable, easy-to-use system for walking pattern analysis in diagnosing orthopedic, sports medicine, and geriatrics (elderly risk of falling) disorders. After recording walking data for several minutes, SenseGo gives immediate results for objective evaluation, improved therapies, and focused follow-up.

MST has developed a video analytics-driven robotic manipulator that tracks and follows surgical tools at the press of a button, allowing surgeons to move independently and hold laparoscopes in a stable, synchronized and precise manner. This enables seamless and fluid surgical workflow, eliminating the need for coordination and communication between surgeons and assistants and providing a stable field of view throughout the procedure. With over 4 million laparoscopic surgeries performed in the U.S. last year, MST estimates a total addressable market of $3B ($2B device sales + $1B disposables). Look for additional materials on MST in the coming weeks on OurCrowd.com by registering as an accredited investor.

Also presenting will be OurCrowd General Partner and CTO, Gadi Mazor. Gadi is an Israeli entrepreneur and an expert in the character and voice recognition space, having served on the advisory board of Blackberry as well as the US Senate committee devising the US public alert system.

Event Details

Host: SPARK

Sponsors: Michigan Israel Business Bridge, University of Michigan Health System

Date: October 16, 2013

Time: 4:30-6:30pm

Location: 215 W Michigan Ave., Ypsilanti, MI

Registration required.

Space is limited to accredited investors only.

RSVP: To attend, RSVP on Eventbrite.

Please note: To hear presentations from the companies we are currently funding and to view the content of our full website, you must accredit online with OurCrowd. If you are not already an accredited investor with OurCrowd, register as an accredited investor on the OurCrowd website. Visit OurCrowd.com, if you meet the U.S. criteria of an “accredited investor,” click JOIN to register.

Who is Trendlines? Partnering with passionate Israeli innovators, Trendlines invents, incubates, and invests in early-stage, high-promise medical and agricultural technologies. Trendlines creates and develops companies to improve the human condition.

Through its active involvement from (before) Day 1, Trendlines provides business and technology development support, marketing, investment banking, finance, and administrative services to its portfolio of 60 innovation-based companies. Trendlines has created an award-winning environment that encourages curiosity, fosters collaboration, and provides investors with significant opportunities.

Who is OurCrowd? OurCrowd is an online platform that gives individuals an innovative way to find and invest in Israeli startups they choose and has raised over $20 million for Israeli companies since February 2013. Jon Medved, one of Israel's most well known entrepreneurs and venture capitalists, created OurCrowd to allow accredited investors to have access to invest in quality, vetted early stage companies. The OurCrowd platform has been featured in the Wall Street Journal, Forbes, CNN, & Bloomberg TV, as well as many Israeli publications.